PALO ALTO, Calif., Aug. 10 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals,
Inc. (Nasdaq: JAZZ) today announced that it will report its second quarter
2009 financial results on Tuesday, August 11, 2009. Jazz Pharmaceuticals will
host an investor conference call and live webcast to discuss the results,
provide guidance for 2009, and give a company update on August 11, 2009, at
5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.
The live webcast and press release may be accessed from the Investors
section of the Jazz Pharmaceuticals' website at www.jazzpharmaceuticals.com.
Please connect to the website prior to the start of the conference call to
ensure adequate time for any software downloads that may be necessary to
listen to the webcast. An archived version of the webcast will be available
through August 25, 2009.
Investors may participate in the conference call by dialing 1-800-299-6183
in the U.S., or 1-617-801-9713 outside the U.S., and entering passcode
52686933.
About Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals is a specialty pharmaceutical company that
identifies, develops and commercializes innovative treatments for important,
underserved markets in neurology and psychiatry. For further information
please see www.jazzpharmaceuticals.com.
SOURCE Jazz Pharmaceuticals, Inc.
08/10/2009
CONTACT: Willie Quinn, Executive Director, Corporate Development of Jazz
Pharmaceuticals, Inc., +1-650-496-2800,
investorinfo@jazzpharmaceuticals.com;
or Karen L. Bergman, +1-650-575-1509, or Michelle Corral, +1-415-794-8662,
both of BCC Partners for Jazz Pharmaceuticals, Inc.
Web Site: http://www.jazzpharmaceuticals.com
(JAZZ)
